Displaying 41 - 60 of 165
FTC Sues to Block Lockheed Martin Corporation’s $4.4 Billion Vertical Acquisition of Aerojet Rocketdyne Holdings Inc.
FTC Sues to Block $40 Billion Semiconductor Chip Merger
FTC Approves Fiscal Year 2020 Hart-Scott-Rodino Premerger Notification Report
Statement of the Commission on the Use of Prior Approval Provisions in Merger Orders
FTC to Restrict Future Acquisitions for Firms that Pursue Anticompetitive Mergers
Federal Trade Commission Withdraws Vertical Merger Guidelines and Commentary
Open Commission Meeting – September 15, 2021
FTC Announces Tentative Agenda for September 15 Open Commission Meeting
Public Access to Illumina/Grail Trial Provided via Teleconference Due to ongoing COVID-19 Concerns
FTC Adjusts its Merger Review Process to Deal with Increase in Merger Filings
FTC Rescinds 1995 Policy Statement that Limited the Agency’s Ability to Deter Problematic Mergers
Statement of FTC Chair Lina M. Khan and Antitrust Division Acting Assistant Attorney General Richard A. Powers on Competition Executive Order’s Call to Consider Revisions to Merger Guidelines
Illumina, Inc., and GRAIL, Inc.
The Federal Trade Commission filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail—a maker of a non-invasive, early detection liquid biopsy test that can screen for multiple types of cancer in asymptomatic patients at very early stages using DNA sequencing. Illumina is the only provider of DNA sequencing that is a viable option for these multi-cancer early detection, or MCED, tests in the United States.
The complaint alleges the proposed acquisition will diminish innovation in the U.S. market for MCED tests, which could be used to detect up to 50 types of cancer. Most of these types of cancer are not screened for at all today, and the MCED test could save millions of lives around the world. The trial is scheduled to begin on Aug. 24, 2021. On May 20, 2021, the FTC authorized staff to dismiss its federal court complaint for Preliminary Injunction and Temporary Restraining Order.
Statement of FTC Acting Bureau of Competition Director Maribeth Petrizzi on Bureau’s Motion to Dismiss Request for Preliminary Relief in Illumina/GRAIL Case
FTC Challenges Illumina’s Proposed Acquisition of Cancer Detection Test Maker Grail
Following Federal Trade Commission Staff Recommendation to Challenge Transaction, Tronox Holding plc. Abandons Proposed Acquisition of TiZir Titanium and Iron
Federal Trade Commission's Commentary on Vertical Merger Enforcement
Displaying 41 - 60 of 165